Free Trial

Revolution Medicines (RVMD) SEC Filings & 10K Form

Revolution Medicines logo
$40.72 +0.08 (+0.20%)
Closing price 04:00 PM Eastern
Extended Trading
$41.32 +0.60 (+1.47%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Revolution Medicines SEC Filings

DateFilerForm TypeView
04/28/2025
5:27 PM
Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4/A
03/24/2025
3:55 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:32 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
4:40 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wang Xiaolin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:40 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:41 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:42 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:43 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:43 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:42 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
4:14 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
3:47 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
3:18 PM
Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:02 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:03 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:00 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:01 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wang Xiaolin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:01 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wei Lin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:02 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:02 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:44 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2025
3:10 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
10:25 AM
JANUS HENDERSON GROUP PLC (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form SCHEDULE 13G
01/22/2025
4:30 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
3:20 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2024
3:50 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:08 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:09 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:06 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:07 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:07 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
8:35 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
7:42 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
7:01 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
6:39 PM
Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:57 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2024
3:18 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
8:37 PM
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form FWP
12/02/2024
4:21 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 424B5
12/02/2024
6:30 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:20 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad)

Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).

Click here for the names of our three top stocks to own this year (no purchase necessary).
11/08/2024
9:52 AM
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/06/2024
4:07 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:05 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:10 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2024
3:42 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:42 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:43 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
3:30 PM
Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/25/2024
5:43 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
5:05 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:07 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:29 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:30 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:30 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:31 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
7:03 AM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2024
3:16 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:23 PM
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Weber Barbara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
3:33 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:33 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:16 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:17 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:17 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:18 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:18 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
6:06 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
5:41 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
5:22 PM
Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:37 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:15 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:24 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
3:23 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
3:15 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:48 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:34 PM
Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2024
4:34 PM
Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:07 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 424B5
08/02/2024
4:35 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:29 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
4:05 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:27 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
7:03 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
3:35 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:36 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:36 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
3:36 PM
Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
3:36 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:19 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:19 PM
Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/28/2024
4:05 PM
Horning Sandra (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4/A
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad)

Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).

Click here for the names of our three top stocks to own this year (no purchase necessary).
06/28/2024
4:06 PM
Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4/A
06/28/2024
4:06 PM
Borisy Alexis (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4/A
06/28/2024
4:07 PM
Kim Lorence H. (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4/A
06/28/2024
4:07 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
Form 4/A
06/28/2024
4:08 PM
Borellini Flavia (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4/A
06/28/2024
4:09 PM
ANDERSON ELIZABETH M (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4/A
06/27/2024
5:48 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
3:20 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:20 PM
ANDERSON ELIZABETH M (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RVMD) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners